BRIEF published on 06/27/2025 at 18:27, 1 year 4 months ago STRATEC SE approuve un dividende de 0,60 € par action Actionnaires Dividende Conseil De Surveillance STRATEC SE Exercice Financier 2024
BRIEF published on 06/27/2025 at 18:27, 1 year 4 months ago STRATEC SE Approves €0.60 Dividend Per Share Shareholders Dividend Supervisory Board Financial Year 2024 STRATEC SE
PRESS RELEASE published on 06/27/2025 at 18:22, 1 year 4 months ago STRATEC ANNUAL GENERAL MEETING APPROVES DIVIDEND DISTRIBUTION OF € 0.60 PER SHARE STRATEC SE shareholders approve dividend distribution of € 0.60 per share at the Annual General Meeting. PwC elected as auditor for 2025 Annual General Meeting Dividend Distribution STRATEC SE PwC 2025 Financial Year
BRIEF published on 05/30/2025 at 07:00, 1 year 5 months ago STRATEC SE Reports Strong First Quarter 2025 Results Software Solutions Sales Increase Financial Growth STRATEC SE Q1 2025 Results
BRIEF published on 05/30/2025 at 07:00, 1 year 5 months ago STRATEC SE publie de solides résultats pour le premier trimestre 2025 Croissance Financière Solutions Logicielles STRATEC SE Augmentation Des Ventes Résultats Du Premier Trimestre 2025
PRESS RELEASE published on 05/30/2025 at 06:55, 1 year 5 months ago STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2025 STRATEC SE reports strong financial results for Q1 2025 with 12.0% sales growth and 8.9% adjusted EBIT margin. New cooperations drive demand for software solutions and product lifecycle management Financial Results Sales Growth Adjusted EBIT Margin STRATEC SE Q1 2025
BRIEF published on 05/19/2025 at 07:05, 1 year 5 months ago STRATEC publie ses résultats financiers pour 2024 Baisse Des Ventes STRATEC SE Résultats Financiers 2024 Augmentation De La Marge EBIT Perspectives 2025
BRIEF published on 05/19/2025 at 07:05, 1 year 5 months ago STRATEC Releases 2024 Financial Results Sales Decline STRATEC SE 2024 Financial Results EBIT Margin Increase 2025 Outlook
PRESS RELEASE published on 05/19/2025 at 07:00, 1 year 5 months ago STRATEC REPORTS RESULTS FOR 2024 FINANCIAL YEAR STRATEC SE reports financial results for the 2024 fiscal year, with adjusted EBIT margin at 13.0% and consolidated sales at €257.6 million, outlook for 2025 and dividend proposal Financial Results 2024 Consolidated Sales Adjusted EBIT Margin STRATEC SE
BRIEF published on 04/23/2025 at 21:12, 1 year 6 months ago STRATEC SE annonce ses résultats préliminaires pour 2024 et ses perspectives pour 2025 Performance Financière Résultats 2024 Retard Du Rapport Annuel Modifications Comptables Prévisions Pour 2025
Published on 11/06/2026 at 22:15, 2 days 8 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:00, 11 minutes ago Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market
Published on 11/09/2026 at 07:00, 11 minutes ago Cicor receives awards for two major defence programmes
Published on 11/09/2026 at 01:55, 5 hours 16 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 19 hours ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 20 hours 55 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/09/2026 at 07:00, 11 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 11 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 11 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 11 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
